| TCRX Stock Yearly Return 2025 Table | ||||||||||||||||||||||||||||||
TCRX average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare TCRX average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| TCRX Share Performance |
| TCRX Stock Yearly Return 2025 Chart | |||
Also see: • TCRX YTD return • TCRX average annual return 10 years | |||
| About TScan Therapeutics Inc |
| TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. Co.'s lead TCR-T therapy candidates, TSC-100 and TSC-101, are in clinical development for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. Co. is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. The TCRX stock yearly return is shown above.
The yearly return on the TCRX stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2025 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the TCRX annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| TCRX Current Stock Quote |
 Free TCRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| TScan Therapeutics (TCRX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
TDOC Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.6%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.6%.
Video: Don't Forget Dividends in Average Annual Return!